Upload Avatar (500 x 500)
Yan Bi
biyan@nju.edu.cn
Chinese, English
Jiangsu
Nanjing University
Medical School
  • Jiangsu Science and Technology Award Second Prize (2019): New Mechanisms and New Technologies for the Diagnosis and Treatment of Diabetes
  • Jiangsu Medical Science and Technology Award First Prize (2018): New Pathophysiological Characteristics and Intervention Targets of Hyperglycemia in Type 2 Diabetes in China
  • Jiangsu Medical New Technology Introduction Award First Prize (2018): Early Screening Technology and Clinical Application of Diabetic Cardiovascular Autonomic Neuropathy
  • Jiangsu Medical New Technology Introduction Award First Prize (2015): Clinical Application of 1H-MRS Quantitative Liver Fat in Evaluating the Efficacy of Hypoglycemic Drugs
  • Chinese Diabetes Top Ten Most Influential Research Award (2015): The Role of Sterol Regulatory Element-Binding Protein-1c in Mediating Skeletal Muscle Insulin Resistance
  • Chinese Diabetes Top Ten Most Influential Research Award (2013): Association of β-cell Function and Insulin Sensitivity with Fasting and 2-h Plasma Glucose in a Large Chinese Population
  • Chinese Insulin Secretion Research New Star Award (2011): Different Effects of Fasting Blood Glucose and 2-hour Post-load Blood Glucose on Insulin Secretion and Insulin Sensitivity
  • Chinese Diabetes Journal Excellent Paper First Prize (2011): Early Insulin Therapy on the Expression of Sterol Regulatory Element-Binding Protein-1c in Skeletal Muscle of Diabetic Rats
  • Jiangsu Science and Technology Award Second Prize (2012): New Molecular Mechanisms and Clinical Diagnosis and Treatment Technologies for Type 2 Diabetes
  • Jiangsu Medical Science and Technology Award Second Prize (2011): Basic and Clinical Research on the Diagnosis and Treatment of Type 2 Diabetes
  • Chinese Medical Science and Technology Award Third Prize (2011): New Molecular Mechanisms and Clinical Diagnosis and Treatment Technologies for Type 2 Diabetes
  • Nanjing Science and Technology Progress Award Second Prize (2011): New Molecular Mechanisms and Clinical Diagnosis and Treatment Technologies for Type 2 Diabetes
  • Jiangsu Medical New Technology Introduction Award Second Prize (2020): Establishment and Practice of a Whole Life Cycle Blood Glucose Management Model with Clinical Pharmacists Participating in Multidisciplinary Teams Based on CDTM
Treatment targets and clinical translation research of type 2 diabetes and obesity
  • Extracellular vesicles mediate the communication of adipose tissue with brain and promote cognitive impairment associated with insulin resistance, Jin Wang, Liang Li, Zhou Zhang, Xuhong Zhang, Ye Zhu, Chenyu Zhang, Yan Bi, 2022
  • Prolactin improves hepatic steatosis via CD36 pathway, Zhang P, Ge Z, Wang H, Feng W, Sun X, Chu X, Jiang C, Wang Y, Zhu D, Bi Y, 2018
  • Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study, Haiyan Cheng, Zhou Zhang, Bing Zhang, Wen Zhang, Jin Wang, Wenyu Ni, Yingwen Miao, Jiani Liu, Yan Bi, 2022
  • Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies, Zhang Z, Zhang B, Wang X, Zhang X, Yang QX, Qing Z, Zhang W, Zhu D, Bi Y, 2019
  • Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity, Wang H, Shen L, Sun X, Liu F, Feng W, Jiang C, Chu X, Ye X, Jiang C, Wang Y, Zhang P, Zang M, Zhu D, Bi Y, 2019
  • Association of Omental Adipocyte Hypertrophy and Fibrosis with Human Obesity and Type 2 Diabetes, Fangcen Liu, Jielei He, Boxun Liu, Pengzi Zhang, Hongdong Wang, Xitai Sun, Xuehui Chu, Wenxian Guan, Wenhuan Feng, Yan Bi, Dalong Zhu, 2021
  • Gender differences in the association of body composition and biopsy-proved nonalcoholic steatohepatitis, Da Fang, Wenjuan Tang, Xiaoyu Zhao, Haixiang Sun, Tianwei Gu, Yan Bi, 2022
  • The association between visceral adipocyte hypertrophy and NAFLD in subjects with different degrees of adiposity, Haixiang Sun, Da Fang, Hongdong Wang, Jin Wang, Yue Yuan, Shanshan Huang, Huayang Ma, Tianwei Gu, Yan Bi, 2022
  • Lower levels of osteocalcin, but not CTX or P1NP, associated with nonalcoholic hepatic steatosis and steatohepatitis, Fang D, Ji XL, Sun HX, Zhao XY, Bi Y, Gu TW, 2022
  • Altered Brain Spontaneous and Synchronization Activity in latent autoimmune diabetes in adults: A Resting-State Functional MRI Study, Miao YW, Wang J, Zhang B, Zhang W, Xu X, Hou YJ, Ding Q, Yu CC, Zhang Z, Bi Y, Zhu DL, 2022
  • One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study, Jing Lu, Shan-Mei Shen, Qing Ling, Bin Wang, Li-Rong Li, Wei Zhang, Duo-Duo Qu, Yan Bi, Da-Long Zhu, 2021
  • Risk of beta-cell antoimmunity presence of progression to type 1 diabetes: a systemic review and meta-analysis, Ling Q, Lu J, Li J, Xu Q, Zhu D, Bi Y, 2018
  • Altered Odor-Induced Brain Activity as an Early Manifestation of Cognitive Decline in Patients with Type 2 Diabetes, Zhang Z, Zhang B, Wang X, Zhang X, Yang QX, Qing Z, Lu J, Bi Y, Zhu D, 2018
Type 2 Diabetes Obesity Treatment Targets Clinical Translation Diabetes Complications Fatty Liver Adipose Tissue Insulin Resistance Cognitive Impairment Non-Alcoholic Fatty Liver Disease

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.